Your search for evid returned 211 results

A regulatory decision is expected on June 22, 2023.

Extended antibiotics do not reduce infection or reconstruction failure after postmastectomy breast reconstruction.

A regulatory decision is expected in August 2023.

The approval was based on studies that included adults with moderately to severely active Crohn disease who had an inadequate response to or were intolerant of biologic therapy.

5α-reductase inhibitors are widely used to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.

Access to list of free preventive health care services will continue while the case winds through the courts, possibly ending up in the Supreme Court.

Updated review of the evidence shows small reduction in risk for SARS-CoV-2 infection with mask use vs no mask use.

Caldolor contains ibuprofen, a nonsteroidal anti-inflammatory drug with analgesic, anti-inflammatory, and antipyretic properties.

The time-based deferrals for men who have sex with men (MSM) and women who have sex with MSM have been eliminated.

A decision on the OTC oral contraceptive pill is expected later this year.